Inventor
LANNUTTI BRIAN
US19 patents
⚠️ This page may combine multiple inventors who share the name “LANNUTTI BRIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACERTA PHARMA BV
9 patentsUS10272083B2Apr 30, 2019
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor
ACERTA PHARMA BV14 citations93
US11771696B2Oct 3, 2023
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor
ACERTA PHARMA BV5 citations85
US11090302B2Aug 17, 2021
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor
ACERTA PHARMA BV4 citations83
US9949971B2Apr 24, 2018
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor and/or a JAK-2 inhibitor
ACERTA PHARMA BV11 citations83
US11654143B2May 23, 2023
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor
ACERTA PHARMA BV3 citations72
US11166951B2Nov 9, 2021
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor
ACERTA PHARMA BV2 citations72
US10328080B2Jun 25, 2019
Therapeutic combination of PI3K inhibitor and a BTK inhibitor
ACERTA PHARMA BV6 citations72
US12263164B2Apr 1, 2025
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor
ACERTA PHARMA BV0 citations62
US11154554B2Oct 26, 2021
Therapeutic combinations of a MEK inhibitor and a BTK inhibitor
ACERTA PHARMA BV0 citations51
ONCTERNAL THERAPEUTICS INC
4 patentsUS10159660B2Dec 25, 2018
Uses of indolinone compounds
ONCTERNAL THERAPEUTICS INC6 citations81
US12161626B2Dec 10, 2024
Uses of indolinone compounds
ONCTERNAL THERAPEUTICS INC1 citations70
US11285132B2Mar 29, 2022
Uses of indolinone compounds
ONCTERNAL THERAPEUTICS INC3 citations70
US10646470B2May 12, 2020
Uses of indolinone compounds
ONCTERNAL THERAPEUTICS INC3 citations70